Methylation Epigenetic Landscape of Cpg DNA Defining CD4 T Cell Memory By

Total Page:16

File Type:pdf, Size:1020Kb

Methylation Epigenetic Landscape of Cpg DNA Defining CD4 T Cell Memory By The Journal of Immunology Defining CD4 T Cell Memory by the Epigenetic Landscape of CpG DNA Methylation H. Kiyomi Komori, Traver Hart, Sarah A. LaMere, Pamela V. Chew, and Daniel R. Salomon Memory T cells are primed for rapid responses to Ag; however, the molecular mechanisms responsible for priming remain incom- pletely defined. CpG methylation in promoters is an epigenetic modification, which regulates gene transcription. Using targeted bisulfite sequencing, we examined methylation of 2100 genes (56,000 CpGs) mapped by deep sequencing of T cell activation in human naive and memory CD4 T cells. Four hundred sixty-six CpGs (132 genes) displayed differential methylation between naive and memory cells. Twenty-one genes exhibited both differential methylation and gene expression before activation, linking pro- moter DNA methylation states to gene regulation; 6 of 21 genes encode proteins closely studied in T cells, whereas 15 genes represent novel targets for further study. Eighty-four genes demonstrated differential methylation between memory and naive cells that cor- related to differential gene expression following activation, of which 39 exhibited reduced methylation in memory cells coupled with increased gene expression upon activation compared with naive cells. These reveal a class of primed genes more rapidly expressed in memory compared with naive cells and putatively regulated by DNA methylation. These findings define a DNA methylation sig- nature unique to memory CD4 T cells that correlates with activation-induced gene expression. The Journal of Immunology, 2015, 194: 1565–1579. ifferentiation into fast-acting memory cells following Ag have a demethylated IL-4 gene promoter (10), do not express IFN-g, recognition is a central tenet of T cell immunology. and have a methylated IFN-g promoter (11, 12). Similarly, Foxp3 D Memory T cells are often described as being “primed” (13–15), IL-2 (6, 16–18), IL-17A (19), and other immune genes have for rapid responses to Ag; however, the molecular mechanisms been shown to be regulated by DNA methylation. responsible for this priming remain incompletely defined. Meth- Although these studies have been performed to look at the impact ylation of CpG dinucleotides in promoter regions is one mecha- of DNA methylation on the expression of single genes, few have nism of epigenetic regulation of gene transcription (1–3). CpG employed a more global examination of DNA methylation in CD4 methylation is maintained during cell division, but it can be al- T cells (20). Indeed, many candidate genes have been screened for tered by aging or environmental stimuli such as disease (1, 4) and promoter CpG methylation in CD4 T cells profiled at rest and T cell activation (5–7). Many genes corresponding to immune following activation (9, 17, 18, 21), during development (3, 22), or function have been identified as being regulated by CpG meth- comparing conventional T cells to regulatory T cells (23). CD4 ylation, implicating a role for CpG methylation in T cell function T cells have also been studied in disease contexts such as latent and differentiation. Clear examples of this phenomenon include autoimmune diabetes in adults (24), bronchial asthma (8), or the patterns of DNA methylation and gene expression for IFN-g systemic lupus erythematosus (25). Recently, Hashimoto et al. (7) and IL-4 in the development of Th1 and Th2 lineages. Differen- conducted a global DNA methylation analysis in murine naive, tiated Th1 cells express IFN-g and exhibit a demethylated IFN-g effector, and memory CD4 T cells. The authors found that most promoter (8, 9). These same cells do not express IL-4 and have differential methylation between naive and memory cells occurred a methylated IL-4 promoter. Conversely, Th2 cells express IL-4, in introns and intergenic regions. Interestingly, the methylation changes occurring following activation of memory CD4 T cells localized to enhancer regions. Department of Molecular and Experimental Medicine, The Scripps Research Insti- To fully appreciate the impact of epigenetic changes in disease tute, La Jolla, CA 92037 states it is important to understand how CpG methylation regulates Received for publication May 6, 2014. Accepted for publication December 8, 2014. function and activation-dependent lineage commitments of human This work was supported by National Institutes of Health Grants U19 A1063603 (to naive and memory CD4 T cells in healthy individuals. We used D.R.S. and T.H.), TL1 TR001113-01 (to S.A.L.), T32DK007022-30, and a postdoc- toral Juvenile Diabetes Research Foundation fellowship (to H.K.K.), and by the deep RNA sequencing (RNA-seq) of naive and memory cells Molly Baber Research Fund and the Verna Harrah Research Fund, supporting the activated by CD3/CD28 crosslinking to identify a set of high-value Salomon Laboratory. This is manuscript 23060 from The Scripps Research Institute. candidate genes for epigenetic regulation. Then, using high-throughput The sequences presented in this article have been submitted to the National Center targeted microdroplet PCR (26), we successfully mapped 57,706 for Biotechnology Information’s Gene Expression Omnibus (http://www.ncbi.nlm. nih.gov/geo/) under accession number GSE59860. CpGs across 1946 selected genes. This study shows an inverse association between promoter CpG Address correspondence and reprint requests to Dr. Daniel R. Salomon, Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 methylation and RNA expression, particularly in genes without North Torrey Pines Road, Mail Code MEM-241, La Jolla, CA 92037. E-mail address: a promoter CpG island (CGI). We identified 132 genes that were [email protected] differentially methylated between CD4 naive and memory subsets. The online version of this article contains supplemental material. In contrast, 48 h following activation, there was surprisingly little Abbreviations used in this article: AIM2, absent in melanoma 2; CGI, CpG island; variation in CpG methylation from resting to activated cells. These FDR, false discovery rate; RNA-seq, RNA sequencing; TSS, transcriptional start site. 132 genes mapped to pathways involved in cellular migration, Copyright Ó 2015 by The American Association of Immunologists, Inc. 0022-1767/15/$25.00 hematological system development and function, and inflammatory www.jimmunol.org/cgi/doi/10.4049/jimmunol.1401162 1566 DNA METHYLATION OF MEMORY CD4 T CELLS responses, consistent with the conclusion that DNA methylation Preparation of bisulfite-converted DNA is important for regulation of CD4 T cell function. Moreover, Bisulfite-converted DNAwas prepared as previously described (26). Briefly, 21 genes exhibited differential methylation between naive and DNA was bisulfite treated using the EpiTect bisulfite kit (Qiagen) fol- memory CD4 T cells that correlated with differential gene ex- lowing the manufacturer’s protocol. Converted DNA was concentrated on pression at rest, and 84 genes demonstrated differential methylation Agencourt AMPure XP beads and quantitated using the Quant-iT ssDNA between memory and naive cells that correlated to differential gene assay kit (Invitrogen) and a Qubit fluorimeter (Invitrogen). expression following activation. Ultimately, we mapped most of RainDance Technologies microdroplet PCR these genes to three pathways involved in delivering a number of Microdroplet PCR was conducted as previously described (26). Briefly, 2 mg critical inflammatory cytokine signals, many with established bi- bisulfite-converted DNA was merged with the CD4-specific 2100 gene ological significance in CD4 T cell activation and innate immunity droplet library and amplified with 55 cycles of PCR. Following amplifica- and many as novel candidates for additional research. tion, the droplet emulsion was broken and the amplified DNA was purified using a MinElute PCR purification kit (Qiagen) following standard protocols. Materials and Methods Preparation of sequencing libraries and deep bisulfite Ethics statement sequencing All of the present studies were covered by Human Subjects Research RainDance Technologies PCR products were concatenated as previously Protocols approved by the Institutional Review Board of The Scripps described (26). Briefly, 400 ng microdroplet PCR product was end-repaired Research Institute. Informed written consent was obtained from all study and concatenated. Concatenated products were then fragmented to 200 bp subjects in the study. using a Covaris S2. Fragmentation was confirmed on an Agilent Tech- nologies Bioanalyzer using an HS DNA chip. Ten to 100 ng fragmented Isolation and activation of human lymphocytes PCR product was end-repaired and A-tailed. Indexed adapters were li- gated, and ligation product was purified on Agencourt AMPure XP beads Peripheral blood was collected from healthy donors, and PBMC were followed by size selection from 2% agarose. Purified product was ampli- collected by centrifugation through a Histopaque (Sigma-Aldrich) gradient. fied with 18 cycles of PCR followed by size selection from 2% agarose. CD4 T cells were negatively selected from PBMC using the naive CD4 Libraries were assessed on an Agilent Technologies Bioanalyzer using T cell isolation kit II (Miltenyi Biotec) or the memory CD4 T cell isolation a DNA chip and quantitated using the Quant-iT dsDNA BR assay kit and kit (Miltenyi Biotec) from six donors. CD8 T cells and B cells were a Qubit fluorimeter. Cluster generation and sequencing on an Illumina positively selected from PBMC using CD8 or CD19 microbeads (Miltenyi HiSequation 2000
Recommended publications
  • Immuno-Oncology Panel 1
    Immuno-Oncology panel 1 Gene Symbol Target protein name UniProt ID (& link) Modification* (56 analytes) ADA17 ADAM17 metalloprotease domain 17 P78536 *blanks mean the assay detects the ANXA1 Annexin A1 P04083 non-modified peptide sequence ANXA1 Annexin A1 P04083 ARG2 arginase, type II P78540 ATM Serine-protein kinase ATM, Ataxia telangiectasia mutated Q13315 pS2996 ATM Serine-protein kinase ATM, Ataxia telangiectasia mutated Q13315 ATM Serine-protein kinase ATM, Ataxia telangiectasia mutated Q13315 pS367 ATM Serine-protein kinase ATM, Ataxia telangiectasia mutated Q13315 C10orf54 / VISTA chromosome 10 open reading frame 54 Q9H7M9 CCL5 C-C motif chemokine ligand 5 P13501 CD14 CD14 molecule P08571 CD163 CD163 molecule Q86VB7 CD274 / PDL1 Programmed cell death 1 ligand 1 CD274 Q9NZQ7 CD33 CD33 molecule P20138 CD40/TNR5 tumor necrosis factor receptor superfamily member 5 P25942 CD40/TNR5 tumor necrosis factor receptor superfamily member 5 P25942 CD47 CD47 molecule Q08722 CD70 CD70 antigen P32970 CD74/HG2A CD74 molecule, major histocompatibility complex, class II invariant chain Q8SNA0 CEACAM8 carcinoembryonic antigen-related cell adhesion molecule 8 P31997 CX3CL1 C-X3-C motif chemokine ligand 1 P78423 CXCL10 C-X-C motif chemokine ligand 10 P02778 CXCL13 chemokine (C-X-C motif) ligand 13 O43927 ENTPD1 ectonucleoside triphosphate diphosphohydrolase 1 Q86VV3 FAS/TNR6 Fas (TNF receptor superfamily, member 6) P25445 pY291 FAS/TNR6 Fas (TNF receptor superfamily, member 6) P25445 GAPDH Glyceraldehyde-3-phosphate dehydrogenase P04406 HAVCR2 hepatitis
    [Show full text]
  • Investigation of Functional Genes at Homologous Loci Identified Based
    Journal of Atherosclerosis and Thrombosis Vol.22, No.5 455 Original Article Investigation of Functional Genes at Homologous Loci Identified Based on Genome-wide Association Studies of Blood Lipids via High-fat Diet Intervention in Rats using an in vivo Approach Koichi Akiyama, Yi-Qiang Liang, Masato Isono and Norihiro Kato Department of Gene Diagnostics and Therapeutics, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan Aim: It is challenging to identify causal (or target) genes at individual loci detected using genome- wide association studies (GWAS). In order to follow up GWAS loci, we investigated functional genes at homologous loci identified using human lipid GWAS that responded to a high-fat, high-choles- terol diet (HFD) intervention in an animal model. Methods: The HFD intervention was carried out for four weeks in male rats of the spontaneously hypertensive rat strain. The liver and adipose tissues were subsequently excised for analyses of changes in the gene expression as compared to that observed in rats fed normal rat chow (n=8 per group). From 98 lipid-associated loci reported in previous GWAS, 280 genes with rat orthologs were initially selected as targets for the two-staged analysis involving screening with DNA microarray and validation with quantitative PCR (qPCR). Consequently, genes showing a differential expression due to HFD were examined for changes in the expression induced by atorvastatin, which was indepen- dently administered to the rats. Results: Using the HFD intervention in the rats, seven known (Abca1, Abcg5, Abcg8, Lpl, Nr1h3, Pcsk9 and Pltp) and three novel (Madd, Stac3 and Timd4) genes were identified as potential signifi- cant targets, with an additional list of 23 suggestive genes.
    [Show full text]
  • Recombinant T-Cell Immunoglobulin and Mucin Domain Containing Protein 4 (TIMD4)
    RPH854Hu01 100µg Recombinant T-Cell Immunoglobulin And Mucin Domain Containing Protein 4 (TIMD4) Organism Species: Homo sapiens (Human) Instruction manual FOR RESEARCH USE ONLY NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES 12th Edition (Revised in Aug, 2016) 1 / 4 [ PROPERTIES ] Source: Prokaryotic expression Host: E.coli Residues: Glu25~Gln314 Tags: N-terminal His Tag Subcellular Location: Secreted Purity: > 95% Traits: Freeze-dried powder Buffer formulation: 100mMNaHCO3, 500mMNaCl, pH8.3, containing 0.01% SKL, 5% Trehalose. Original Concentration: 100µg/mL Applications: Positive Control; Immunogen; SDS-PAGE; WB. (May be suitable for use in other assays to be determined by the end user.) Predicted isoelectric point: Predicted Molecular Mass: 35.0kDa Accurate Molecular Mass: 40kDa as determined by SDS-PAGE reducing conditions. Phenomenon explanation: The possible reasons that the actual band size differs from the predicted are as follows: 1.Splice variants: Alternative splicing may create different sized proteins from the same gene. 2. Relative charge: The composition of amino acids may affects the charge of the protein. 3. Post-translational modification: Phosphorylation, glycosylation, methylation etc. 4. Post-translation cleavage: Many proteins are synthesized as pro-proteins, and then cleaved to give the active form. 5. Polymerization of the target protein: Dimerization, multimerization etc. [ USAGE ] Reconstitute in 100mM NaHCO3, 500mM NaCl (pH8.3) to a concentration of 0.1-1.0 mg/mL. Do not vortex. 2 / 4 [ STORAGE AND STABILITY ] Storage: Avoid repeated freeze/thaw cycles. Store at 2-8ºC for one month. Aliquot and store at -80ºC for 12 months. Stability Test: The thermal stability is described by the loss rate.
    [Show full text]
  • Immune-Checkpoint Blockade Therapy in Lymphoma
    International Journal of Molecular Sciences Review Immune-Checkpoint Blockade Therapy in Lymphoma Ayumi Kuzume 1,2, SungGi Chi 1 , Nobuhiko Yamauchi 1 and Yosuke Minami 1,* 1 Department of Hematology, National Cancer Center Hospital East, Kashiwa 277–8577, Japan; [email protected] (A.K.); [email protected] (S.C.); [email protected] (N.Y.) 2 Department of Hematology, Kameda Medical Center, Kamogawa 296–8602, Japan * Correspondence: [email protected]; Tel.: +81-4-7133-1111; Fax: +81-7133-6502 Received: 11 June 2020; Accepted: 28 July 2020; Published: 30 July 2020 Abstract: Tumor cells use immune-checkpoint pathways to evade the host immune system and suppress immune cell function. These cells express programmed cell-death protein 1 ligand 1 (PD-L1)/PD-L2, which bind to the programmed cell-death protein 1 (PD-1) present on cytotoxic T cells, trigger inhibitory signaling, and reduce cytotoxicity and T-cell exhaustion. Immune-checkpoint blockade can inhibit this signal and may serve as an effective therapeutic strategy in patients with solid tumors. Several trials have been conducted on immune-checkpoint inhibitor therapy in patients with malignant lymphoma and their efficacy has been reported. For example, in Hodgkin lymphoma, immune-checkpoint blockade has resulted in response rates of 65% to 75%. However, in non-Hodgkin lymphoma, the response rate to immune-checkpoint blockade was lower. In this review, we evaluate the biology of immune-checkpoint inhibition and the current data on its efficacy in malignant lymphoma, and identify the cases in which the treatment was more effective.
    [Show full text]
  • Supplementary Materials
    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
    [Show full text]
  • Targeting Costimulatory Molecules in Autoimmune Disease
    Targeting costimulatory molecules in autoimmune disease Natalie M. Edner1, Gianluca Carlesso2, James S. Rush3 and Lucy S.K. Walker1 1Institute of Immunity & Transplantation, Division of Infection & Immunity, University College London, Royal Free Campus, London, UK NW3 2PF 2Early Oncology Discovery, Early Oncology R&D, AstraZeneca, Gaithersburg, MD, USA 3Autoimmunity, Transplantation and Inflammation Disease Area, Novartis Institutes for Biomedical Research, Basel, Switzerland *Correspondence: Professor Lucy S.K. Walker. Institute of Immunity & Transplantation, Division of Infection & Immunity, University College London, Royal Free Campus, London, UK NW3 2PF. Tel: +44 (0)20 7794 0500 ext 22468. Email: [email protected]. 1 Abstract Therapeutic targeting of immune checkpoints has garnered significant attention in the area of cancer immunotherapy, and efforts have focused in particular on the CD28 family members CTLA-4 and PD-1. In autoimmunity, these same pathways can be targeted to opposite effect, to curb the over- exuberant immune response. The CTLA-4 checkpoint serves as an exemplar, whereby CTLA-4 activity is blocked by antibodies in cancer immunotherapy and augmented by the provision of soluble CTLA-4 in autoimmunity. Here we review the targeting of costimulatory molecules in autoimmune disease, focusing in particular on the CD28 family and TNFR family members. We present the state-of-the-art in costimulatory blockade approaches, including rational combinations of immune inhibitory agents, and discuss the future opportunities and challenges in this field. 2 The risk of autoimmune disease is an inescapable consequence of the manner in which the adaptive immune system operates. To ensure effective immunity against a diverse array of unknown pathogens, antigen recognition systems based on random gene rearrangement and mutagenesis have evolved to anticipate the antigenic universe.
    [Show full text]
  • 1 Self-Maintaining Gut Macrophages Are Essential for Intestinal
    Self-maintaining Gut Macrophages Are Essential for Intestinal Homeostasis De Schepper Sebastiaan1*, Verheijden Simon1*†, Aguilera-Lizarraga Javi1, Viola Maria Francesca1, Boesmans Werend2, Stakenborg Nathalie1, Voytyuk Iryna3, Smidt Inga3, Boeckx Bram4,5, Dierckx de Casterlé Isabelle6, Baekelandt Veerle7, Gonzalez Dominguez Erika1, Mack Matthias8, Depoortere Inge9, De Strooper Bart3, Sprangers Ben4, Himmelreich Uwe10, Soenen Stefaan10, Guilliams Martin11, Vanden Berghe Pieter2, Jones Elizabeth12, Lambrechts Diether5,6, Boeckxstaens Guy1 1Laboratory for Intestinal Neuroimmune Interactions, Translational Research Center for Gastrointestinal Disorders, Department of Chronic Diseases, Metabolism and Ageing, University of Leuven, Leuven, Belgium. 2Laboratory for Enteric Neuroscience, Translational Research Center for Gastrointestinal Disorders, Department of Chronic Diseases, Metabolism and Ageing, University of Leuven, Leuven, Belgium. 3VIB – KU Leuven Center for Brain and Disease Research, Leuven, Belgium. 4VIB Center for Cancer Biology, Leuven, Belgium. 5Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium. 6Laboratory of Experimental Transplantation, Department of Microbiology and Immunology, University of Leuven, Leuven, Belgium. 7Research Group for Neurobiology and Gene Therapy, Department of Neurosciences, University of Leuven, Leuven, Belgium. 8Department of Internal Medicine – Nephrology, University Hospital Regensburg, Regensburg, Germany. 9Gut Peptide Research Lab, Translational
    [Show full text]
  • Self-Renewing Resident Cardiac Macrophages Limit Adverse Remodeling Following Myocardial Infarction
    JOURNAL CLUB 3/19/19 SAHIL MAHAJAN ARTICLES https://doi.org/10.1038/s41590-018-0272-2 Corrected: Publisher Correction Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction Sarah A. Dick1,2,11, Jillian A. Macklin 1,2,3,4,11, Sara Nejat 1,11, Abdul Momen1, Xavier Clemente-Casares1, Marwan G. Althagafi1,4, Jinmiao Chen 5,6, Crystal Kantores 1, Siyavash Hosseinzadeh1,4, Laura Aronoff1,4, Anthony Wong 1,7, Rysa Zaman 1,7, Iulia Barbu1,7, Rickvinder Besla1,4, Kory J. Lavine8, Babak Razani8,9, Florent Ginhoux 5,6, Mansoor Husain1,2,3,4,10, Myron I. Cybulsky1,4,10, Clinton S. Robbins1,4,7,10 and Slava Epelman 1,2,3,4,7,10* Macrophages promote both injury and repair after myocardial infarction, but discriminating functions within mixed populations remains challenging. Here we used fate mapping, parabiosis and single-cell transcriptomics to demonstrate that at steady state, TIMD4+LYVE1+MHC-IIloCCR2− resident cardiac macrophages self-renew with negligible blood monocyte input. Monocytes par- tially replaced resident TIMD4–LYVE1–MHC-IIhiCCR2− macrophages and fully replaced TIMD4−LYVE1−MHC-IIhiCCR2+ macro- phages, revealing a hierarchy of monocyte contribution to functionally distinct macrophage subsets. Ischemic injury reduced TIMD4+ and TIMD4– resident macrophage abundance, whereas CCR2+ monocyte-derived macrophages adopted multiple cell fates within infarcted tissue, including those nearly indistinguishable from resident macrophages. Recruited macrophages did not express TIMD4, highlighting the ability of TIMD4 to track a subset of resident macrophages in the absence of fate map- ping. Despite this similarity, inducible depletion of resident macrophages using a Cx3cr1-based system led to impaired cardiac function and promoted adverse remodeling primarily within the peri-infarct zone, revealing a nonredundant, cardioprotective role of resident cardiac macrophages.
    [Show full text]
  • Pancancer IO360 Human Vapril2018
    Gene Name Official Full Gene name Alias/Prev Symbols Previous Name(s) Alias Symbol(s) Alias Name(s) A2M alpha-2-macroglobulin FWP007,S863-7,CPAMD5 ABCF1 ATP binding cassette subfamily F member 1 ABC50 ATP-binding cassette, sub-family F (GCN20),EST123147 member 1 ACVR1C activin A receptor type 1C activin A receptor, type IC ALK7,ACVRLK7 ADAM12 ADAM metallopeptidase domain 12 a disintegrin and metalloproteinase domainMCMPMltna,MLTN 12 (meltrin alpha) meltrin alpha ADGRE1 adhesion G protein-coupled receptor E1 TM7LN3,EMR1 egf-like module containing, mucin-like, hormone receptor-like sequence 1,egf-like module containing, mucin-like, hormone receptor-like 1 ADM adrenomedullin AM ADORA2A adenosine A2a receptor ADORA2 RDC8 AKT1 AKT serine/threonine kinase 1 v-akt murine thymoma viral oncogene homologRAC,PKB,PRKBA,AKT 1 ALDOA aldolase, fructose-bisphosphate A aldolase A, fructose-bisphosphate ALDOC aldolase, fructose-bisphosphate C aldolase C, fructose-bisphosphate ANGPT1 angiopoietin 1 KIAA0003,Ang1 ANGPT2 angiopoietin 2 Ang2 ANGPTL4 angiopoietin like 4 angiopoietin-like 4 pp1158,PGAR,ARP4,HFARP,FIAF,NL2fasting-induced adipose factor,hepatic angiopoietin-related protein,PPARG angiopoietin related protein,hepatic fibrinogen/angiopoietin-related protein,peroxisome proliferator-activated receptor (PPAR) gamma induced angiopoietin-related protein,angiopoietin-related protein 4 ANLN anillin actin binding protein anillin (Drosophila Scraps homolog), actin bindingANILLIN,Scraps,scra protein,anillin, actin binding protein (scraps homolog, Drosophila)
    [Show full text]
  • The Indoleamine 2,3 Dioxygenase Pathway Drives Intratumoral B Cell
    bioRxiv preprint doi: https://doi.org/10.1101/2021.08.25.456776; this version posted August 27, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The indoleamine 2,3 dioxygenase pathway drives intratumoral B cell maintenance. by Burles A. Johnson III1,2,3, Adam K. Aragaki2, Donna M. Williams3, Ophelia Rogers3, Jack Mountain2, Li Luo3, Wenhao Zhang3, Lingling Xian3, Mingxiao Feng2, Lionel Chia3, Dominic Dordai4, Noah M. Hahn1,2, Stephen Desiderio4, Theodore S. Johnson5, David J. McConkey2, and Linda M.S. Resar1,3,6. 1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205 2Johns Hopkins Greenberg Bladder Cancer Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Park 219, Baltimore, MD 21287 3Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross Research Building, Room 1025, Baltimore, MD 21205 4Institute for Basic Biomedical Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205 5Georgia Cancer Center and Department of Pediatrics, Augusta University, 1120 15th Street, Augusta, GA 30912 6Department of Pathology and Institute for Cellular Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205 Abstract: 219 words; Manuscript Text: 4929 words Correspondence: [email protected] or [email protected] Abbreviations: IDO1, indoleamine 2,3 dioxygenase-1; Bregs, regulatory B cells, Tregs, regulatory T cells; LLC, Lewis Lung Carcinoma; PD-1/L, programmed cell death protein-1/ligand; APCs, antigen presenting cells; MDSCs, myeloid derived suppressor cells; IL, interleukin. bioRxiv preprint doi: https://doi.org/10.1101/2021.08.25.456776; this version posted August 27, 2021.
    [Show full text]
  • Innate and Adaptive Immune Functions of Peyer's Patch
    Innate and Adaptive Immune Functions of Peyer’s Patch Monocyte-Derived Cells Article Innate and Adaptive Immune Functions of Peyer’s Patch Monocyte-Derived Cells Johnny Bonnardel, Clément da Silva, Sandrine Henri, Samira Tamoutounour, Lionel Chasson, Frederic Montañana-Sanchis, Jean-Pierre Gorvel, Hugues Lelouard To cite this version: Johnny Bonnardel, Clément da Silva, Sandrine Henri, Samira Tamoutounour, Lionel Chasson, et al.. Innate and Adaptive Immune Functions of Peyer’s Patch Monocyte-Derived Cells Article Innate and Adaptive Immune Functions of Peyer’s Patch Monocyte-Derived Cells. Cell Reports, Elsevier Inc, 2015, pp.770-784. 10.1016/j.celrep.2015.03.067. hal-01212685 HAL Id: hal-01212685 https://hal-amu.archives-ouvertes.fr/hal-01212685 Submitted on 7 Oct 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Article Innate and Adaptive Immune Functions of Peyer’s Patch Monocyte-Derived Cells Graphical Abstract Authors Johnny Bonnardel, Cle´ ment Da Silva, ..., Jean-Pierre Gorvel, Hugues Lelouard Correspondence [email protected] In Brief Bonnardel et al. provide a comprehensive analysis of the phenotype, distribution, ontogeny, lifespan, function, and transcriptional profile of Peyer’s patch (PP) mononuclear phagocyte system.
    [Show full text]
  • Timd4 Rat Monoclonal Antibody [Clone ID: RMT4-54] Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for AM60019PU-S Timd4 Rat Monoclonal Antibody [Clone ID: RMT4-54] Product data: Product Type: Primary Antibodies Clone Name: RMT4-54 Applications: FC, IF, IHC Recommended Dilution: Flow cytometry: 1/25-1/200, use 10µl of this suggested working dilution to label 10e6 cells in 100µl. Immunofluorescence. Immunohistochemistry on Paraffin sections. Positive control: Mouse spleen. For functional assays Cat.-No. AM60019LE-N is recommended. Reactivity: Mouse Host: Rat Isotype: IgG2a Clonality: Monoclonal Immunogen: Mouse TIMD4 (amino acids 1-288), coupled with the Fc portion of mouse IgG2a Specificity: Clone RMT4-54 specifically recognises mouse Tim-4. Studies have shown that clone RMT4-54 significantly inhibits the efficient phagocytosis of apoptotic cells by PRMs (peritoneal resident Mac1+ cells), but not PEMs (peritoneal exudate Mac1+ cells) [Nakayama, 2009]. Formulation: PBS containing 0.09% Sodium azide State: Purified State: Liquid purified IgG Concentration: lot specific Purification: Affinity chromatography on Protein G Conjugation: Unconjugated Storage: Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Stability: Shelf life: one year from despatch. Gene Name: T cell immunoglobulin and mucin domain containing 4 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 Timd4 Rat Monoclonal Antibody [Clone ID: RMT4-54] – AM60019PU-S Database Link: Entrez Gene 276891 Mouse Q6U7R4 Background: TIMD4 / TIM-4 (T-cell immunoglobulin mucin 4), a transmembrane glycoprotein and member of the immunoglobulin superfamily, exclusively expressed by antigen-presenting cells, which acts as the natural ligand of TIM-1, involved in T-cell expansion and cytokine production.
    [Show full text]